Luprostiol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11425 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 62 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | benign prostatic hyperplasia (disease) | KG + DL |
| 2 | congestive heart failure | KG + DL |
| 3 | Prinzmetal angina | KG + DL |
| 4 | acute pulmonary heart disease | KG + DL |
| 5 | Raynaud disease | KG + DL |
| 6 | myocardial infarction | KG + DL |
| 7 | posteroinferior myocardial infarction | KG + DL |
| 8 | posterolateral myocardial infarction | KG + DL |
| 9 | chronic renal failure syndrome | KG + DL |
| 10 | hypotensive disorder | KG + DL |
| 11 | septal myocardial infarction | KG + DL |
| 12 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 13 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 14 | diabetic nephropathy | KG + DL |
| 15 | allergic asthma | KG + DL |
| 16 | chronic kidney disease | KG + DL |
| 17 | intracranial arteriosclerosis | KG + DL |
| 18 | headache disorder | KG + DL |
| 19 | intrinsic asthma | KG + DL |
| 20 | trigeminal autonomic cephalalgia | KG + DL |
| 21 | end stage renal failure | KG + DL |
| 22 | intermittent vascular claudication | KG + DL |
| 23 | chronic pulmonary heart disease | KG + DL |
| 24 | obsolete hyperuricemia (disease) | KG + DL |
| 25 | subarachnoid hemorrhage (disease) | KG + DL |
| 26 | Monckeberg arteriosclerosis | KG + DL |
| 27 | intracerebral hemorrhage | KG + DL |
| 28 | transient ischemic attack (disease) | KG + DL |
| 29 | endocardial fibroelastosis | KG + DL |
| 30 | high output heart failure | KG + DL |
| 31 | type 1 diabetes mellitus | KG + DL |
| 32 | ischemia reperfusion injury | KG + DL |
| 33 | endocarditis | KG + DL |
| 34 | hemoglobinopathy | KG + DL |
| 35 | intracranial abscess | KG + DL |
| 36 | hepatic porphyria | KG + DL |
| 37 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 38 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 39 | gout | KG + DL |
| 40 | IDDM 1 | KG + DL |
| 41 | heart failure | KG + DL |
| 42 | primitive portal vein thrombosis | KG + DL |
| 43 | hepatoportal sclerosis | KG + DL |
| 44 | idiopathic copper-associated cirrhosis | KG + DL |
| 45 | hepatopulmonary syndrome | KG + DL |
| 46 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 47 | priapism | KG + DL |
| 48 | renal osteodystrophy | KG + DL |
| 49 | short bowel syndrome | KG + DL |
| 50 | malignant renovascular hypertension | KG + DL |
(Showing top 50 of 62 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.